AP-VAS 2012 case report: MPO-ANCA-negative relapse of MPO-ANCA-associated vasculitis

被引:0
作者
Yoshinori Komagata
Kazufumi Nomura
Ken Yoshihara
Soko Kawashima
Shinya Kaname
Yoshihiro Arimura
Akira Yamada
机构
[1] Kyorin University School of Medicine,First Department of Internal Medicine
关键词
ANCA-associated vasculitis; MPO-ANCA-positive GPA; Relapse; ELISA;
D O I
10.1007/s13730-013-0100-3
中图分类号
学科分类号
摘要
A 79-year-old female was admitted to our hospital with fever, proteinuria, hematuria, high levels of C-reactive protein (CRP), and high titer of myeloperoxidase antineutrophil cytoplasmic antibody (MPO-ANCA). Our diagnosis was microscopic polyangiitis (MPA) and she was treated with steroid pulse therapy. Clinical remission was induced; however, the disease relapsed with saddle nose and necrotizing vasculitis of the nasal cavity mucosa 1 year later. Although there was no elevation of the MPO-ANCA titer, we diagnosed the patient with relapse of MPO-ANCA-positive granulomatosis with polyangiitis (GPA). Remission was induced again with steroids and azathioprine. It has been reported that the number of MPO-ANCA-positive patients in Asian countries is relatively higher than in Western countries. We checked 29 GPA patients in our hospital and 9 patients (31.0 %) were MPO-ANCA-positive. In addition, it is not rare that an ANCA-associated vasculitis (AAV) patient who has been in remission with negative ANCA relapses without any elevation of ANCA titer. We checked the transition of ANCA titer of 24 AAV patients in our hospital who relapsed and 6 patients (25 %) relapsed without any elevation of ANCA titer. We should be careful for a relapse, even if the ANCA titer remains negative. It is also possible that ANCA had been changed so as not to be detected by the same enzyme-linked immunosorbent assay (ELISA) kit. Thus, it is also important to change the detection system if clinical symptoms are worsened while ANCA is still negative.
引用
收藏
页码:180 / 183
页数:3
相关论文
共 157 条
[1]  
Hagen EC(1998)Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization Kidney Int 53 743-753
[2]  
Daha MR(2012)ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes Clin Exp Nephrol 16 580-588
[3]  
Hermans J(2012)Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study Mod Rheumatol 22 394-404
[4]  
Andrassy K(2007)Renal histology in Chinese patients with anti-myeloperoxidase autoantibody-positive Wegener’s granulomatosis Nephrol Dial Transplant 22 139-145
[5]  
Csernok E(2009)ANCA associated vasculitis and PRGN Nihon Jinzo Gakkai Shi 51 88-93
[6]  
Gaskin G(1991)Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis Nephrol Dial Transplant 6 689-694
[7]  
Lesavre P(2000)Prediction of relapses in Wegener’s granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study Arthritis Rheum 43 2025-2033
[8]  
Lüdemann J(2007)Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis Ann Intern Med 147 611-619
[9]  
Rasmussen N(2003)Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis Kidney Int 63 1079-1085
[10]  
Sinico RA(2009)A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis Ann Rheum Dis 68 228-233